Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about SutroBiopharmaInc-2020-12-08
$145.0 Million
Image
Sutro Biopharma, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CogentBiosciences-2020-12-01
$115.0 Million
Image
Cogent Biosciences
Follow-On Offering
Active Bookrunner
Read more
about ProtagonistTherapeuticsInc-2020-12-10
$115.0 Million
Image
Protagonist Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about KerosTherapeutics-2020-11-17
$149.5 Million
Image
Keros Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about AptinyxInc-2020-10-21
$48.3 Million
Image
Aptinyx Inc.
Follow-On Offering
Active Bookrunner
Read more
about PhreesiaInc-2020-10-20
$184.0 Million
Image
Phreesia Inc.
Follow-On Offering
Passive Bookrunner
Read more
about AccoladeInc-2020-10-21
$221.3 Million
Image
Accolade, Inc
Follow-On Offering
Passive Bookrunner
Read more
about IMabBiopharma-2021-02-08
$203.9 Million
Image
I-Mab Biopharma
Follow-On Offering
Active Bookrunner
Read more
about SurgalignHoldingsInc-2021-01-27
$43.0 Million
Image
Surgalign Holdings, Inc.
Follow-On Offering
Left Bookrunner
Read more
about SeresTherapeuticsInc-2020-08-12
$225.8 Million
Image
Seres Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 49
Next page
››
Subscribe to Equity Capital Markets
